PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Similarly, in obese NAFLD versus nonobese non-NAFLD, none showed risk for NAFLD under codominant model; however, females (AOR = 3.411, 95% CI 0.997–11.671; p = 0.051), and PNPLA3 genotype GG + CG (AOR = 3.270, 95% CI 1.131–9.455; p = 0.029) revealed significantly higher risk for NAFLD under dominant model, and illiterates (AOR = 3.323, 95% CI 1.010–10.937; p = 0.048) and PNPLA3 genotype GG (AOR = 4.534, 95% CI 1.221–16.826; p = 0.024) revealed significantly higher risk for NAFLD under recessive model (see Table 5).